Evidence map›Paper›PMID 29396538›Full record

ArticleScientific reports2018

Repeated five-day administration of L-BMAA, microcystin-LR, or as mixture, in adult C57BL/6 mice - lack of adverse cognitive effects.

Oddvar Myhre, Dag Marcus Eide, Synne Kleiven, Hans Christian Utkilen, Tim Hofer

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Environmental Neurotoxin β-Microorganisms · 2022
    Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Oddvar MyhreDepartment of Toxicology and Risk Assessment, Norwegian Institute of Public Health (NIPH), Oslo, Norway.ORCID http://orcid.org/0000-0002-8635-4699
Dag Marcus EideDepartment of Toxicology and Risk Assessment, Norwegian Institute of Public Health (NIPH), Oslo, Norway.ORCID http://orcid.org/0000-0001-5017-0145
Synne KleivenDepartment of Natural Sciences and Environmental Health, University College of Southeast Norway, Bø, Norway.ORCID http://orcid.org/0000-0002-6761-2293
Hans Christian UtkilenDepartment of Natural Sciences and Environmental Health, University College of Southeast Norway, Bø, Norway.ORCID http://orcid.org/0000-0001-6120-7898
Tim HoferDepartment of Toxicology and Risk Assessment, Norwegian Institute of Public Health (NIPH), Oslo, Norway. tim.hofer@fhi.no.ORCID http://orcid.org/0000-0003-4757-2033

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cyanobacterial toxins β-methylamino-L-alanine (L-BMAA) and microcystin-LR (MC-LR; a potent liver toxin) are suspected to cause neurological disorders. Adult male C57BL/6JOlaHsd mice aged approximately 11 months were subcutaneously injected for five consecutive days with L-BMAA and microcystin-LR alone, or as a mixture. A dose-range study determined a tolerable daily dose to be ~31 µg MC-LR/kg BW/day based on survival, serum liver status enzymes, and relative liver and kidney weight. Mice tolerating the first one-two doses also tolerated the subsequent three-four doses indicating adaptation. The LD

Indexed as

Amino Acids, DiaminoAnimalsCognitionCyanobacteria ToxinsEnzyme InhibitorsExcitatory Amino Acid AgonistsInjections, SubcutaneousKidneyLethal Dose 50LiverLiver Function TestsMaleMarine ToxinsMemoryMice, Inbred C57BLMicrocystinsAmino Acids, Diaminobeta-N-methylamino-L-alanineCyanobacteria Toxinscyanoginosin LREnzyme InhibitorsExcitatory Amino Acid AgonistsMarine ToxinsMicrocystins

Identifiers

PMID29396538
PMCPMC5797144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.